Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
Apyx Medical Corporation (NASDAQ:APYX) announced participation in the JMP Securities Life Sciences Conference on June 16-17, where management will engage in a fireside chat on June 16 at 10:30 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through the company’s investor relations website, with an archive available post-conference. Apyx Medical specializes in Helium Plasma Technology, marketed as Renuvion® and J-Plasma®, which offers innovative solutions for cosmetic and surgical markets.
- None.
- None.
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that management will participate in the JMP Securities Life Sciences Conference, which is being held virtually from June 16th-17th. Management will participate in a fireside chat on Wednesday, June 16th at 10:30 a.m. Eastern Time.
A live audio webcast of the presentation will be provided under the ‘Company Events’ section of the Apyx Medical Corporation investor relations website at https://apyxmedical.com/investor_relations/. An archive of the webcast will be available for replay following the conference.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company’s Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion® offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma® system allows surgeons to operate with a high level of precision while minimizing unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210603005216/en/
FAQ
When is Apyx Medical Corporation participating in the JMP Securities Life Sciences Conference?
What time will Apyx Medical's management participate in the fireside chat?
How can I access the webcast of Apyx Medical's presentation?
What products does Apyx Medical Corporation offer?